Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Total Non-Current Liabilities (2019 - 2025)

Bioadaptives' Total Non-Current Liabilities history spans 7 years, with the latest figure at $617153.0 for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $617153.0 for Q4 2025, down 8.24% from a year ago — trailing twelve months through Dec 2025 was $617153.0 (down 8.24% YoY), and the annual figure for FY2025 was $617153.0, down 8.24%.
  • Total Non-Current Liabilities for Q4 2025 was $617153.0 at Bioadaptives, down from $622164.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.3 million in Q3 2021 to a low of $502577.0 in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $678568.0 (2021), against an average of $711729.7.
  • The sharpest move saw Total Non-Current Liabilities soared 137.88% in 2021, then dropped 12.97% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $684582.0 in 2021, then increased by 17.15% to $801959.0 in 2022, then decreased by 3.64% to $772757.0 in 2023, then dropped by 12.97% to $672554.0 in 2024, then fell by 8.24% to $617153.0 in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $617153.0, $622164.0, and $547177.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.